News
Pharma update | PI judge holds fingolimod 0.5 mg patent provisionally invalid
In its interim relief decision of 21 June 2022 the PI Judge of the District Court of The Hague held Novartis’ EP 2 959 894 (“EP 894”) re fingolimod 0.5 mg provisionally invalid. This is the first substantive PI decision on this matter in Europa, where several proceedings between Novartis and Mylan are pending. In
Read more ›
BarentsKrans advises Van de Velde Packaging on the acquisition of Dozenhal
BarentsKrans has advised Van de Velde Packaging on the acquisition of Dozenhal. Dozenhal has two warehouses and a production facility in the Netherlands and a sales team in Germany. The company claims to have “the largest stock of cardboard boxes in the Netherlands”. “Corrugated cardboard boxes are produced in small quantities at the production location
Read more ›
Pharma update | Apixaban patent and SPC provisionally held invalid
In its decision of 10 May 2022 in PI proceedings between Bristol-Myers Squibb Holdings Ireland Unlimited Company (“BMS”) and Sandoz B.V. (“Sandoz”), the PI judge of the District Court of The Hague denied BMS’ claim for injunctive relief regarding the sale of generic apixaban by Sandoz. According to the Judge, there is no inventive step
Read more ›
Court finds Mammoet’s press release unlawful
Huisman had issues a press announcement that it had concluded an agreement with BMW for the design and construction of a so-called “ringer crane”, a special kind of heavy-lifting land cranes. Following Huisman’s press statement, Mammoet issued a press release entitled “Mammoet starts investigation of patent infringement by Huisman and BMS”, in which it refers
Read more ›
BarentsKrans repels Novartis’ bid for fingolimod PI
The District Court of The Hague (Provisions Judge) has rejected Novartis’ application, based on a patent application, for a preliminary injunction (PI), meaning Mylan can market its generic drug containing fingolimod in the Netherlands at least prior to the grant of the patent. The EPO’s Technical Board of Appeal had recently cleared the way for
Read more ›
Legal 500 EMEA 2022: “Partner involvement, all areas in-house, professional juniors”
This week the Legal 500 published its’ 2022 edition. We are honoured to again have received excellent rankings this year. BarentsKrans has been ranked as Top Tier Firm in Employment Law and has been recommended in no less than ten practice areas. A special mention goes to Joost Fanoy who was listed as Leading Individual
Read more ›
Banking Litigation Network conference at BarentsKrans
Last Friday BarentsKrans hosted the annual Banking Litigation Network conference. The Banking Litigation Network is a network of law firms from around the world with specialist experience of acting for clients in disputes with banks and other financial institutions. Its’ main objective is to provide members with ready access to a law firm in another
Read more ›
Pharma update | Market entry of generic fingolimod before patent grant is not unlawful
In its interim decision of 22 March 2022 the PI judge of the District Court of The Hague ruled in the PI proceedings in Novartis v Mylan that the market entry by Mylan with its generic fingolimod 0.5mg product prior to Novartis’ patent entering into force, is not unlawful. Given the very short time between
Read more ›
BarentsKrans has advised Quadrum Capital on its investment in JASA Group
A team of BarentsKrans has advised investment company Quadrum Capital with its investment in JASA Group. JASA develops, assembles and produces packaging machines and complete weighing and packaging lines. The team is led by Eduard de Haan, who as CEO has already successfully worked together with a large part of the management. “We are very
Read more ›
BarentsKrans advised Benedictus Holding B.V. and T. Kuyvenhoven Holding B.V. on the sale of Liones Holding B.V.
BarentsKrans has advised Benedictus Holding B.V. and T. Kuyvenhoven Holding B.V. on the sale of Liones Holding B.V., a company that provides software for structured content authoring through its Dutch subsidiaries (among which Fonto Group B.V.), to SDL Holdings B.V., a (indirect) subsidiary of the British RWS Holdings. Through this sale, Liones Holding B.V. and
Read more ›
